LF 08‐0299 Protects Murine Recipients of Minor Antigen Disparate Donor Marrow from Lethal Graft‐versus‐Host Disease
- 17 December 1995
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 770 (1), 373-375
- https://doi.org/10.1111/j.1749-6632.1995.tb31073.x
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Graft-versus-host disease: new directions for a persistent problemBlood, 1994
- FK506 inhibits graft-versus-host disease and bone marrow graft rejection in murine recipients of MHC disparate donor grafts by interfering with mature peripheral T cell expansion post-transplantation.The Journal of Immunology, 1994
- Murine recipients of fully mismatched donor marrow are protected from lethal graft-versus-host disease by the in vivo administration of rapamycin but develop an autoimmune-like syndrome.The Journal of Immunology, 1993
- DEOXYSPERGUALIN IN LETHAL MURINE GRAFT-VERSUS-HOST DISEASETransplantation, 1991
- Graft-versus-host mortality induced by noncytolytic CD4+ T cell clones specific for non-H-2 antigens.The Journal of Immunology, 1990